Dr. Fischette is CEO of BioLinkUp, LLC, a Corporate Strategy/Business Development Consulting entity and spends much of her time with financial advisory firms in New York. Formerly, she was President of Enzo Therapeutics, Inc., a division of Enzo Biochem (ENZ: NYSE), and has spent 25+ years at Roche, Novartis and Pfizer with increasing areas of responsibility in strategic and operational roles covering multiple therapeutic areas.  She directed the entire drug development process and subsequent marketing effort for an anti-diabetes therapy, Glucotrol XL®, and became Head of Pfizer’s US commercial diabetes division where sales eventually reached ca. $300m. She functioned as Head of Negotiation, Global Business Development & Licensing for various therapeutic Business Franchise Boards at Novartis Pharmaceuticals where she sourced, negotiated and executed multiple deals involving various deal structures, including asset acquisitions, with US, European, Japanese and Indian companies. Dr. Fischette holds a Ph.D. in Physiology from the Rutgers Biomedical Health Sciences, formerly University of Medicine and Dentistry of New Jersey, and has authored over 50 publications in peer-reviewed publications, including Science.